Virtu Financial LLC Standard Biotools Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.65 - $2.92 $39,931 - $70,666	24,201 New	24,201 $43,000
Q4 2022 Feb 15, 2023	BUY	$0.93 - $1.52 $15,035 - $24,573	16,167 New	16,167 $19,000
Q2 2022 Aug 09, 2022	SELL	$1.6 - $3.99 $22,832 - $56,937	-14,270 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$2.8 - $3.96 $39,956 - $56,509	14,270 New	14,270 $51,000
Q2 2018 Jul 30, 2018	SELL	$4.86 - $6.24 $62,130 - $79,772	-12,784 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$4.86 - $6.24 $62,130 - $79,772	12,784 New	12,784 $76,000
Q1 2018 May 14, 2018	SELL	$5.75 - $7.97 $77,757 - $107,778	-13,523 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$4.46 - $6.45 $60,312 - $87,223	13,523	13,523 $80,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.